Word

ONTELRIQ

Status

Dead

Status Code

402

Status Date

Saturday, April 29, 2023

Serial Number

79337831

Mark Type

4000

Filing Date

Wednesday, February 16, 2022

Published for Opposition

Tuesday, September 26, 2023

Abandoned Date

Sunday, April 30, 2023

Trademark Owner History

IPSEN PHARMA S.A.S - Owner At Publication

Classifications

5 Pharmaceutical preparations for use in the prevention and the treatment of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty diseases or disorders, gynecological disorders, fertility, acromegalia and tumors, hormonal disorders, endocrine disorders, connective tissue disease, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, muscle disorders, bone disorders, skeletal disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospam, migraine, bladder pain syndrome, pain, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; Pharmaceutical preparations containing notably botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other botulinum toxin derivatives for skin care and the treatment of neurological disorders; pharmaceutical preparations containing botulinum toxin with specified components of the toxin haemagglutin complex for skin care and the treatment of neurological disorders

Trademark Events

Nov 21, 2023

Notification Of Effect Of Cancellation Of Intl Reg E-Mailed

Nov 20, 2023

Death Of International Registration

Oct 31, 2023

Notification Processed By Ib

Oct 3, 2023

Notification Of Possible Opposition - Processed By Ib

Sep 26, 2023

Official Gazette Publication Confirmation E-Mailed

Sep 26, 2023

Published For Opposition

Sep 13, 2023

Notification Of Possible Opposition Sent To Ib

Sep 13, 2023

Notification Of Possible Opposition Created, To Be Sent To Ib

Sep 6, 2023

Notification Of Possible Opposition Sent To Ib

Sep 6, 2023

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Sep 6, 2023

Notification Of Notice Of Publication E-Mailed

Aug 22, 2023

Approved For Pub - Principal Register

Jul 19, 2023

Teas/Email Correspondence Entered

Jul 19, 2023

Correspondence Received In Law Office

Jul 19, 2023

Teas Response To Office Action Received

Feb 27, 2023

Refusal Processed By Ib

Jan 27, 2023

Non-Final Action Mailed - Refusal Sent To Ib

Jan 27, 2023

Refusal Processed By Mpu

Dec 10, 2022

Non-Final Action (Ib Refusal) Prepared For Review

Dec 9, 2022

Non-Final Action Written

Dec 1, 2022

Assigned To Examiner

Apr 12, 2022

Application Filing Receipt Mailed

Apr 8, 2022

New Application Office Supplied Data Entered

Apr 7, 2022

Sn Assigned For Sect 66a Subseq Desig From Ib